Sphera Biotech US Fund, L.P.
Sphera Biotech US Fund, L.P. is a hedge fund based in Tel Aviv, Israel. According to its most recent Form D, filed Apr 27, 2026, the fund has sold $32,071,088 of interests to 11 investors since its first sale in Oct 2018. The minimum investment it accepts from an outside investor is $500,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Doron Breen; Nir Arkin; Adi Hanetz.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
The firm that manages it, Sphera Funds Management LTD., files Form 13F. Its page shows the firm's disclosed stock holdings and an estimate derived from them. Those figures describe the firm as a whole, not this fund.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $32,071,088Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Oct 1, 2018
- Minimum investment
- $500,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Doron Breen; Nir Arkin; Adi Hanetz
- Latest Form D
- Apr 27, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 27, 2026 | Form D/A (amendment) | $32,071,088 | 11 | SEC.gov ↗ |
| Apr 14, 2025 | Form D/A (amendment) | $32,071,088 | 11 | SEC.gov ↗ |
| Apr 16, 2024 | Form D/A (amendment) | $31,821,088 | 10 | SEC.gov ↗ |
| Apr 27, 2023 | Form D/A (amendment) | $31,821,088 | 10 | SEC.gov ↗ |
| Apr 28, 2022 | Form D/A (amendment) | $31,821,088 | 10 | SEC.gov ↗ |
| May 12, 2021 | Form D/A (amendment) | $15,991,088 | 5 | SEC.gov ↗ |
| May 13, 2020 | Form D/A (amendment) | $10,691,088 | 3 | SEC.gov ↗ |
| Oct 10, 2019 | Form D/A (amendment) | $10,100,000 | 2 | SEC.gov ↗ |
| Oct 9, 2018 | Form D | $5,100,000 | 2 | SEC.gov ↗ |
9 Form D filings in the SEC's electronic records (2008 onward), the earliest on Oct 9, 2018. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Sphera Biotech US Fund, L.P.
What is the minimum investment for Sphera Biotech US Fund, L.P.?
According to its latest Form D, filed Apr 27, 2026, the minimum investment Sphera Biotech US Fund, L.P. accepts from an outside investor is $500,000.
Who can invest in Sphera Biotech US Fund, L.P.?
Sphera Biotech US Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Sphera Biotech US Fund, L.P. raised?
Sphera Biotech US Fund, L.P. reports $32,071,088 sold from 11 investors on its Form D filed Apr 27, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Sphera Biotech US Fund, L.P. based?
Sphera Biotech US Fund, L.P. is based in Tel Aviv, Israel and is managed by Sphera Funds Management LTD..
When did Sphera Biotech US Fund, L.P. launch?
Sphera Biotech US Fund, L.P. reports its first sale in Oct 2018.
Size compared with every hedge fund
Raised more than 77% of the 13 hedge funds based in Israel, and more than 38% of all 10,161 that report sales.